My site

FOSHAN, China - Friday, 29. March 2024 AETOSWire

(BUSINESS WIRE)--Midea Group:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240328526418/en/

Background:

Midea Group, a leading global technology group, recently released its 2023 Environmental, Social, and Governance (ESG) Report with ambitious sustainable development goals set for 2030.

They include achieving over 500 megawatts of photovoltaic power generation, reducing greenhouse gas emission intensity (scopes 1 and 2) by 0.040, secure Energy Management System Certification for 50 factories, and achieve 100% carbon footprint accounting for major categories of smart home appliances.

This is aligned with the Sustainable Development Report Standards of the Global Report Standards of the Global Reporting Initiative (GRI).

The new report and campaign focuses on four dimensions: Protect the Blue Planet, Build a Harmoniou ... Read more »

 The deal will mark approximately $1 billion of investments in acquisitions since Q4 2023 and positions Blue Yonder to provide a unified end-to-end supply chain platform and collaboration ecosystem

(BUSINESS WIRE)--Blue Yonder, a leader in digital supply chain transformations, continues its forward momentum to revolutionize the supply chain and has today announced the signing of an agreement to acquire  ... Read more »

DURHAM, N.C. - Monday, 01. April 2024

(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), today announced the appointment of Peter Carbone as the new Chief Quality Officer, strengthening KBI’s expertise in Quality and Regulatory Affairs.

A highly respected and successful industry leader, Peter brings over 35 years of experience in operations, quality, and technology leadership in a diverse range of areas in the life sciences spectrum, including biotechnology, pharmaceuticals, and advanced therapies. Peter will lead KBI’s Quality and Regulatory Affairs team, spearheading compliance and regulatory initiatives for customers worldwide and positioning KBI to provide the services, expertise, and leadership to partner with health authorities on regulatory policy.

"We have made a commitment to establishing KBI Biopharma as a thought leader and catalyst for change ... Read more »